Catalyst
Slingshot members are tracking this event:
Data from Phase 2 MS trial expected to be presented at a major medical meeting in the first half of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| TGTX | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 28, 2017
Occurred Source:
http://ir.tgtherapeutics.com/releasedetail.cfm?ReleaseID=1023549
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2, Ms Trial
